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Abstract
Background: Diabetes is the sixth leading cause of death and results in significant morbidity. The
purpose of this study is to determine what demographic, health status, treatment, access/quality of
care, and behavioral factors are associated with poor glycemic control in a Type 2 diabetic, low-
income, minority, San Diego population.
Methods: Longitudinal observational data was collected on patients with Type 2 diabetes from
Project Dulce, a program in San Diego County designed to care for an underserved diabetic
population. The study sample included 573 patients with a racial/ethnic mix of 53% Hispanic, 7%
black, 18% Asian, 20% white, and 2% other. We utilized mixed effects models to determine the
factors associated with poor glycemic control using hemoglobin A1C (A1C) as the outcome of
interest. A multi-step model building process was used resulting in a final parsimonious model with
main effects and interaction terms.
Results: Patients had a mean age of 55 years, 69% were female, the mean duration of diabetes was
7.1 years, 31% were treated with insulin, and 57% were obese. American Diabetes Association
(ADA) recommendations for blood pressure and total cholesterol were met by 71% and 68%,
respectively. Results of the mixed effects model showed that patients who were uninsured, had
diabetes for a longer period of time, used insulin or multiple oral agents, or had high cholesterol
had higher A1C values over time indicating poorer glycemic control. The younger subjects also had
poorer control.
Conclusion: This study provides factors that predict glycemic control in a specific low-income,
multiethnic, Type 2 diabetic population. With this information, subgroups with high risk of disease
morbidity were identified. Barriers that prevent these patients from meeting their goals must be
explored to improve health outcomes.
Background
Approximately 13 million people have been diagnosed
with diabetes in the United States and an additional 5.2
million do not yet know they have the disease [1]. Of
these people, 90–95% have Type 2 diabetes [2]. Diabetes
has been among the top ten leading causes of death in the
Published: 17 April 2005
BMC Public Health 2005, 5:36 doi:10.1186/1471-2458-5-36
Received: 25 October 2004
Accepted: 17 April 2005
This article is available from: http://www.biomedcentral.com/1471-2458/5/36
© 2005 Benoit et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9
(page number not for citation purposes)
BMC Public Health 2005, 5:36 http://www.biomedcentral.com/1471-2458/5/36United States since 1932 and is now the sixth leading
cause of death [3]. Because of the magnitude of the bur-
den of disease, the Healthy People 2010 objectives
include goals of reducing diabetes-related deaths and
increasing the monitoring frequency of glucose control
and chronic complications [4]. The United Kingdom Pro-
spective Diabetes Study and Kumamoto study confirm
that improved glucose control reduces the microvascular
complications in Type 2 diabetes such as retinopathy,
nephropathy, and neuropathy [5,6]. Because of these
findings, new standards of care and new models of health
care delivery have emerged [7].
Disease management programs that incorporate group
patient education, nutrition consultation, case manage-
ment as well as close clinical care have been effective [8].
Project Dulce, an initiative of Community Health
Improvement Partners, the Council of Community Clin-
ics, and The Whittier Institute for Diabetes was started in
1998 in San Diego County. The program has a multifac-
eted approach and focuses on providing care to minority
groups that often lack access to medical services.
Although it is known that improved glycemic control
improves microvascular outcomes, less is known about
the factors that influence control. Harris et al. [9] exam-
ined racial and ethnic differences in glycemic control in
patients with Type 2 diabetes using the Third National
Health and Nutrition Examination Survey (NHANES III)
and found that black women, Mexican-American men,
those treated with insulin or oral antiglycemic medica-
tions, and patients over 60 years of age had poorer glyc-
emic control. Shorr et al. [10] studied the relationship
between age and glycemic control and found no signifi-
cant differences between age groups. Nichols et al. [11]
found that age, body mass index (BMI) and emotional
distress were significantly related to glycemic control in a
health maintenance organization population in Oregon.
Blaum et al. [12] found that disease duration, C peptide
levels, poor self-care, and failure to receive diet recom-
mendations were related to control in a mostly white, pri-
mary care population in Michigan. Project Dulce,
however, is a distinct population of low-income, multi-
ethnic patients with a high proportion of Hispanics and
Asians. Therefore, it is useful to study patient characteris-
tics associated with glycemic control in this unique set-
ting. Prior studies have not accounted for fluctuations in
glycemic control over time. We used a longitudinal data
analysis approach to account for glycemic variation and
thus maximized the amount of information that can be
drawn from the data.
Methods
Data study sample
Project Dulce is a nurse-based diabetes disease manage-
ment system in San Diego, California [13]. Patients with
diabetes are referred to Project Dulce by primary care pro-
viders. Once the patient is referred, the nurse educator
conducts an initial assessment and follows the American
Diabetes Association (ADA) standards of appropriate
physical and laboratory exams and referrals to specialists
(7). Hemoglobin A1C (A1C) is monitored quarterly and
lipids, urine microalbumin, thyroid stimulating hormone
(TSH), and retinal exams are completed yearly or more
frequently as needed. At each visit, height, weight, blood
pressure, foot exams, and glucometer results are reviewed.
The nurse educator is the case manager and follows-up on
missed patient appointments and identifies individual
service and access needs of his/her panel of patients. The
nurse also communicates with the primary care physician
regarding clinical care issues. Project Dulce Dieticians see
patients referred by the nurse educators. The program is
active in seventeen sites including community clinics and
hospital ambulatory care centers throughout San Diego
County. Project Dulce uses the same procedures and
supervision at each site and tracks patients with the Dia-
betes Electronic Management System (DEMS) software.
The database contains demographic, health status, treat-
ment, laboratory, and behavioral factors for each patient
and collects the information over time. This study
included data from July 18, 2000 to October 7, 2002 and
was approved by the Institutional Review Board of San
Diego State University.
Eligibility criteria
For purposes of this analysis, we selected patients with
Type 2 diabetes, reducing the population size from 1,728
to 1,357. To avoid bias and ensure that the study popula-
tion was actively participating in the Project Dulce pro-
gram, inclusion criteria were established. The patient
required: 1) at least two A1C values at least six months
apart, 2) participation in the program for at least six
months, and 3) at least three Project Dulce provider visits.




Demographic variables included gender, age, race/ethnic-
ity, and primary language. All were of low socioeconomic
status. For purposes of this study, five racial/ethnic catego-
ries were created: Hispanic, Asian (including Indian),
black, white, and other.Page 2 of 9
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A1C is a laboratory value that indicates glycemic control
over a 2 to 3 month period; values less than 7% are con-
sidered optimal. A1C was our outcome of interest and was
evaluated over time by examining the patients' A1C labo-
ratory results over a 24 month period. Since Project Dulce
follows the ADA recommendations of checking A1C val-
ues every 3 months, values were placed in 3 month block
intervals, using the patients' initial provider visit as the ref-
erence starting point. A1C laboratory data on individual
patients was not always precisely three months apart so
approximations were necessary. Since A1C is an indicator
of glycemic control over a 2 to 3 month period, we used a
plus or minus 1.5 month approximation. For example, a
three-month lab was considered an A1C measurement 1.5
to 4.5 months after the initial Project Dulce visit. A base-
line A1C value was considered a measurement between
2.8 months before the initial Project Dulce visit to 1.5
months after the visit. Since a two year time period was of
interest in this study, only A1C values falling within 2.8
months of the initial visit or 25.5 months after this visit
were included in the analysis. If more than one A1C value
was available in a particular 3 month time block, the first
measurement within that block was used.
c. Diabetes severity
The difference in dates of the patient's initial Project Dulce
visit and the diabetes diagnosis date estimated disease
duration in years. Medicines used for glucose control
(insulin, sulfonylureas, metformin, glitazones, alpha glu-
cosidase inhibitors, meglitinides) were categorized into
three levels: 1) insulin alone or insulin with oral agents, 2)
more than one oral agent but no insulin, and 3) one oral
medication or no medication at all. Since a patient's phar-
macotherapy changed over time, we created a coding
strategy. If the patient used insulin at any point over the
two year study period, he/she was placed in the insulin
category. Similarly, if the patient ever used more than one
oral medication but never used insulin, the patient was
placed in the more than one oral agent category.
d. Health status
Clinical characteristics considered included systolic (SBP)
and diastolic (DBP) blood pressure, total and HDL cho-
lesterol, urine microalbumin-to-creatinine ratio, and BMI.
Mean values of the clinical variables were used over the
appropriate time period. In univariate analysis, cutpoints
were created based on ADA guidelines [7]. Hypertension
was considered SBP or DBP greater than or equal to 130
mm Hg and 80 mm Hg, respectively. Total cholesterol or
HDL greater than equal to 200 mg/dl and 45 mg/dl,
respectively were defined as dyslipidemia. Urine micro-
albumin-to-creatinine levels between 30 and 299 ug/mg
was considered microalbuminuria and greater than or
equal to 300 ug/mg was considered clinical albuminuria.
BMI greater than or equal to 30 kg/m2 was considered
obese.
e. Access / quality of care
Most of the patients in Project Dulce have County Medical
Services, an insurance program funded by San Diego
County to care for the medically indigent adult popula-
tion (MIA). The remainder are uninsured and pay out-of-
pocket to enroll in the program or are covered by Medi-
care, Medicaid, or private insurance. For purposes of this
study insurance status was categorized as uninsured, MIA,
or insured (insured = Medicare, Medicaid or private insur-
ance). The number of provider visits, duration in the pro-
gram, and whether the patient was seen by a Project Dulce
nutritionist was also recorded.
f. Behavioral factors
Behavioral factors in the model included smoking and the
number of Project Dulce diabetes education classes
attended.
Descriptive and Univariate analysis
The number and proportion of patients were recorded for
each variable within demographic, diabetes severity,
health status, access/quality of care, and behavioral factor
groups. In addition, mean A1C values were compared
across levels of each variable. Univariate analysis using a
t-test or One-Way ANOVA was used to assess significant
differences in mean A1C. If significant differences were
found in ANOVA, the Duncan function in SAS 8.1 was
used to asses individual differences.
Mixed effects model
Mixed effects models were used to assess glycemic control
by analyzing the repeated measure data of A1C values.
The A1C values were skewed and therefore log trans-
formed in order to meet the normal distribution assump-
tion. Several correlation structures including Compound
Symmetry, Unstructured, First-order Autoregressive, and
Toeplitz were assessed for each model. We used Akaike's
Information Criterion (AIC) to select the appropriate cor-
relation structure [14]. All model fittings were imple-
mented using SAS PROC MIXED and the model with the
smallest AIC was considered the best fit [15].
Univariate associations were performed to assess the best
functional form of the variables. Continuous variables
were assessed as linear and curve-linear with the addition
of quadratic terms. Using a hierarchical model building
process, clusters of variables were added in, one-by-one.
All models included baseline A1C and time (in months)
since these two variables were considered essential to con-
trol for in assessing glycemic control in the longitudinal
format. In each model, the AIC of the best-fitted correla-
tion structure was noted.Page 3 of 9
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n (%) Mean A1C (%) p value
Demographic factors
Gender, n (%) 0.99
1. Female 392 (68.7%) 7.63
2. Male 179 (31.4%) 7.63
Age, n (%) Mean = 55.4 ± 10.1 < 0.0001
1. < 50 years 149 (26.0%) 7.89 1 > 2, 3
2. 50–65 355 (62.0%) 7.57
3. > 65 69 (12.0%) 7.36
Ethnicity, n (%) < 0.0001
1. Hispanic 304 (53.3%) 7.84 2 > 3, 4
2. Black 39 (6.8%) 7.96 4 < 2
3. Asian 100 (17.5%) 7.06 3 < 1,2, 5
4. Other 11 (1.9%) 7.46
5. White 116 (20.4%) 7.55
Primary Language, n (%) 0.18
1. Not English 302 (52.8%) 7.58
2. English 270 (47.2%) 7.68
Diabetes severity
Diabetes duration, n (%) Mean = 7.1 ± 7.1 < 0.0001
1. < 1 year 122 (21.9%) 7.04 4 > 3 > 2 > 1
2. 1 – 5 years 195 (34.9%) 7.45
3. 6 – 10 years 93 (16.7%) 7.77
4. > 10 years 148 (26.5%) 8.19
Medicine, n (%) < 0.0001
1. Insulin alone or insulin + oral agents 177 (30.9%) 8.32 1 > 2 > 3
2. > 1 oral agent (no insulin) 284 (49.6%) 7.58
3. No medicine or 1 oral agent 112 (19.5%) 6.47
Health status
Systolic blood pressure, n (%) Mean = 125.2 ± 11.9 0.33
1. < 130 mm Hg 404 (70.5%) 7.65
2. ≥ 130 mm Hg 169 (29.5%) 7.57
Diastolic blood pressure, n (%) Mean = 72.1 ± 6.6 0.19
1. < 80 mm Hg 506 (88.3%) 7.64
2. ≥ 80 mm Hg 67 (11.7%) 7.48
Total cholesterol, n (%) Mean = 187.6 ± 36.0 < 0.0001
1. < 200 mg/dl 386 (68.2%) 7.45
2. ≥ 200 mg/dl 180 (31.8%) 8.03
HDL, n (%) Mean = 45.3 ± 12.0 0.27
1. ≤ 45 mg/dl 322 (56.6%) 7.73
2. > 45 mg/dl 247 (43.4%) 7.59
Urine Microalbumin / creatinine, n (%) Mean = 139.9 ± 480.7 < 0.0001
1. < 30 ug/mg 356 (63.6%) 7.40 3 > 2 > 1
2. 30 – 299 ug/mg 160 (28.6%) 7.84
3. ≥ 300 ug/mg 44 (7.8%) 8.55
Body Mass Index, n (%) Mean = 32.5 ± 7.5 0.003
1. < 30 kg/m2 246 (43.2%) 7.50
2. ≥ 30 kg/m2 323 (56.8%) 7.72Page 4 of 9
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at an alpha level of 0.15 were placed together in a separate
model. Finally, a parsimonious mean effects model was
created, leaving only variables significant at the alpha
level of 0.05. Variable by time interaction terms were
entered into the parsimonious mean effects model in a
clustered process. Significant interaction terms at the
alpha level of 0.05 were then placed together with the par-
simonious model. Once the model variables were final-
ized, correlation structures for fixed and random effects
were verified.
Results
Table 1 shows the study population characteristics and
univariate associations of factors with glycemic control.
a. Demographics
There were more females (68.7%) than males (31.3%).
The mean age was 55.4 years and the younger group had
a higher mean A1C (7.9%) than the other two age groups.
Hispanics represented 53.3% of the study sample and
Asians had lower mean A1C values (7.1%) than Hispanics
(7.8%), blacks (8.0%), and whites (7.6%). The majority
of the patients (52.8%) used a language other than Eng-
lish as their primary language.
b. Diabetes severity
The mean duration of diabetes was 7.1 years and increas-
ing duration of disease resulted in progressively higher
mean A1C values. Insulin users comprised 30.9% of the
study population and had higher mean A1C values
(8.3%) than multiple oral medication users (7.6%) and
those on one oral agent or no medication (6.5%).
c. Health status
Mean systolic and diastolic blood pressures were within
ADA target recommendations (less than 130 and 80 mm
Hg, respectively) with 70.5% and 88.3% of the study pop-
ulation, respectively, meeting the goals. Mean total cho-
lesterol was 187.6 mg/dl and those with lower total
cholesterol (less than 200 mg/dl) had lower mean A1C
values (7.5%) than those with higher total cholesterol
levels (8.0%). Patients with clinical albuminuria com-
prised 7.8% of the study population and had higher mean
A1C values (8.6%) than those with microalbuminuria
(7.8%) and those with no microalbuminuria (7.4%). The
Access/quality of care
Insurance, n (%) < 0.0001
1. Uninsured 169 (29.5%) 8.10 1 > 2, 3
2. County Medical Services 249 (43.5%) 7.39
3. Insurance 155 (27.0%) 7.50
Number of provider visits, n (%) Mean = 10.2 ± 4.4 0.002
1. 3 – 6 118 (20.6%) 7.72 4 > 2, 3
2. 7 – 10 225 (39.3%) 7.56
3. 11 – 15 166 (29.0%) 7.51
4. > 15 64 (11.1%) 7.93
Duration in program, n (%) Mean = 15.7 ± 5.5 0.0001
1. 6 – 12 months 212 (37%) 7.88
2. > 12 – 24 months 361 (63%) 7.53
Seen by nutritionist, n (%) 0.32
1. Yes 475 (82.9%) 7.61
2. No 98 (17.1%) 7.71
Behavioral Factors
Smoking habit, n (%) 0.29
1. Current 63 (12.5%) 7.58
2. Past 162 (32.0%) 7.60
3. Never 281 (55.5%) 7.72
Diabetes Classes Attended, n (%) Mean = 1.5 ± 3.0 0.002
1. 0 358 (74.3%) 7.60 2 > 1 > 3
2. 1–4 42 (8.7%) 7.88
3. 5 + 82 (17.0%) 7.31
Multiple comparison tests in ANOVA were done with the Duncan function in SAS 8.1
Table 1: Population characteristics and univariate associations of factors with mean A1C. Project Dulce, 2000–2002 (N = 573) Page 5 of 9
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higher mean A1C values (7.7%) than those who were not
obese (7.5%).
d. Access / quality of care
The largest (43.5%) group of patients were enrolled in San
Diego County Medical Services followed by the uninsured
(29.5%). Uninsured patients had higher mean A1C values
(8.1%) than those with insurance (7.5%) or County Med-
ical Services (7.4%). Most (63.0%) of the study patients
were enrolled in Project Dulce over one year and this
group had lower mean A1C values (7.5%) compared to
the group enrolled for one year or less (7.9%). Patients
with greater than 15 provider visits had higher mean A1C
values (7.9%) than those with less provider visits. The
majority (82.9%) of the patients had seen a Project Dulce
nutritionist.
e. Behavioral factors
Current smokers comprised 12.5% of the study popula-
tion. Patients who attended 5 or more Project Dulce dia-
betes classes had lower (7.3) mean A1C values than those
who attended no classes (7.6) and those attending 1 to 4
classes (7.9).
Table 2 provides the regression results for the multivariate
mixed effects model analysis which illustrates the factors
associated with glycemic control. Insurance status, disease
duration, pharmacotherapy, and cholesterol level were
significantly associated with glucose control. Fluctuation
in mean A1C over time also differed by age (age*month).
Using the insured as the reference group, the uninsured
had a 5.2% higher A1C level. Patients who had diabetes
over ten years had a 15.3% higher A1C level compared to
those who had diabetes less than one year. Similarly,
patients who had diabetes six to ten years and one to five
years had significantly higher A1C values compared to
those with diabetes less than one year. Patients who
required insulin had a 22.4% higher A1C and those who
required more than one oral medication had a 12.0%
higher A1C compared to hose who used one oral medica-
tion or no medication at all. On average, for every 0.65
mmol/l (25 mg/dl) increase in total cholesterol, the A1C
value was 2.6% higher.
How mean A1C fluctuated over time differently for vari-
ous age groups is best interpreted with a plot. Although
age was a continuous variable in this analysis, for pur-
poses of interpretation, we created three categories. Figure
1 demonstrates that the less than 50 years of age group ini-
tially declined in A1C from baseline to three months but
then slowly rose during the next fifteen months. The two
older age groups had lower mean A1C values that fluctu-
ated during those fifteen months.
Conclusion
Univariate analysis indicates that multiple variables are
associated with glycemic control. Age, race/ethnicity, dis-
ease duration, medication, number of Project Dulce visits,
duration in Project Dulce, total cholesterol,
Table 2: Multivariate mixed effects model to assess characteristics associated with glycemic control. Project Dulce, 2000–2002 (N = 
555)
Estimate p value Translation*
Baseline A1C 0.06050 <0.0001
Month (0 – 24) <0.0001
Insurance 0.003
Uninsured 0.02198 0.06 5.2% increase in A1C 1
County Medical Services (MIA) -0.01300 0.20
Insured (ref) - -
Diabetes duration <0.0001
> 10 years 0.06169 <0.0001 15.3% increase in A1C
6 – 10 years 0.03555 0.008 8.5% increase in A1C
1 – 5.9 years 0.03253 0.003 7.8% increase in A1C
< 1 year (ref) - -
Medicine <0.0001
Insulin alone or insulin + oral agents 0.08768 <0.0001 22.4% increase in A1C
> 1 oral agent (no insulin) 0.04930 <0.0001 12.0% increase in A1C
No medicine or 1 oral agent (ref) - -
Total cholesterol (0.65 mmol/l (25 mg/dl) 
interval)
0.01115 <0.001 2.6% increase in A1C
Age * month <0.001
* Formula for calculating change in A1C = 10(estimate) - 1
110(0.02198) - 1 = 0.052Page 6 of 9
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and the number of diabetes classes attended were all sig-
nificant. However, after controlling for baseline A1C, time
and other demographic, disease severity, health status,
and access/quality of care factors, only age, insurance sta-
tus, disease duration, pharmacotherapy, and total choles-
terol were significant in the final model with main effects
or two-way interaction terms.
The association of insurance status with glycemic control
contradicts previous studies. Harris et al. [9] did not find
an association between glycemic control and insurance
coverage or socioeconomic status using NHANES III data,
a representative sample of the U.S. population. Similarly,
the Michigan community study [12], a study of blacks and
whites in South Carolina [16], and a study of whites and
Mexican-Americans in Texas [17] did not find an associa-
tion between glycemic control and socioeconomic status.
Our population, however, is distinct. It is a multiracial/
ethnic population and all have a low socioeconomic sta-
tus. Within this low-income population, the uninsured
had poorer glycemic control. They represent a subgroup of
patients that struggle to find care for a disease that
requires close monitoring. Their disease state may have
been out-of-control before entering Project Dulce and
thus more difficult to gain control. They may also have
lacked self-care skills or basic knowledge of diabetes since
their care in the past was likely sporadic. Perhaps, factors
such as dietary practices, physical exercise, and education
level were important predictors and differed in this sub-
group [18,19]. Providers may have difficulty procuring
medication and equipment for this group of patients. All
of these factors could help explain the discrepancy but
were not accounted for in this study.
Study findings have differed on the association of glyc-
emic control and disease duration. Similar to Blaum et al.
[12] and contradictory to Nichols et al. [11], we found
that the longer someone had been diagnosed with diabe-
tes, the harder it was to maintain glycemic control.
Although self-care skills could improve with longer dura-
tion of disease, resistance to medication and the need for
higher doses or additional medications increase over
time. Insulin use is also a factor of disease severity and was
Fluctuation in mean A1C values over time by age groupigure 1
Fluctuation in mean A1C values over time by age group. Project Dulce, 2000–2002Page 7 of 9
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mean A1C value (8.3%) of insulin users in our study was
equivalent to the mean value of insulin users in the
NHANES III data [9]. They also found insulin users to
have poorer glucose control.
Among health status factors, high total cholesterol was
associated with poorer glycemic control. Since patients
with diabetes are already at high risk for cardiovascular
disease, this finding reinforces the need to aggressively
screen and treat elevated cholesterol.
Although other health status factors were not associated
with glycemic control in multivariate analysis, it is impor-
tant to assess the health status of Project Dulce patients
compared to other populations. Harris [20] studied
health status and outcomes using NHANES III. Blood
pressure was elevated (greater than or equal to 140/90
mm Hg) in 55% to 65% of the population compared to
Project Dulce's 30% for SBP (greater than 130 mm Hg)
and 12% for DBP (greater than 80 mm Hg). Total choles-
terol was greater than or equal to 200 mg/dl in 62% to
69% of the NHANES III population compared to 32% of
the Project Dulce population. Cigarette smokers compre-
ised 18% to 24% of NHANES III and 13% of Project
Dulce. The prevalence of microalbuminuria and obesity,
however, was higher in the Project Dulce population than
NHANES III, 36.4% vs. 26% to 30% and 57% vs. 34% to
54%, respectively. The fact that a higher proportion of
Project Dulce patients compared to a representative sam-
ple of the U.S. population were meeting ADA blood pres-
sure and cholesterol recommendations suggests the
positive impact and importance of community disease
management programs in low-income, multiracial/ethnic
communities.
Prior studies have demonstrated race/ethnicity as a predic-
tor of glycemic control with higher proportions of poorly
controlled patients among black women and Mexican-
American men [9]. In univariate analysis, our study found
that Asians had better glycemic control than Hispanics,
blacks, and whites. However, this relationship disap-
peared in multivariate analysis after taking other factors
into account. Perhaps the reason why our finding differs
from other studies is that regardless of race/ethnicity, all
study patients were of low socioeconomic status. Prior
studies examined race/ethnicity in populations with dif-
fering socioeconomic status levels.
Similar to results from Shorr et al.'s study [10] using
NHANES III data, our study found that in multivariate
analysis, age was not a significant main effect in predicting
glucose control. However, the significant age by time
interaction term (age*month) indicates that A1C patterns
over time differed between age groups. Figure 1 shows
that while the 50 to 65 and 65 and over age groups' A1C
values fluctuated over time, the younger age group's A1C
values steadily rose. Nichols et al. [11] also found poorer
metabolic control among the younger age group. Since
our longitudinal analysis accounted for fluctuations in
A1C values, we were able to study A1C pattern differences.
It would be interesting to see if this same A1C pattern dif-
ference among age groups exists in a representative sam-
ple of the U.S. population.
The strength of the current study was the use of mixed
effects models. This is the first study that used a longitudi-
nal approach to find factors associated with glycemic con-
trol. Incorporating repeated measures over time accounts
for fluctuations in glucose control and maximizes the
amount of information that can be drawn from the data.
Another advantage was the size and diversity of the popu-
lation which included large numbers of Hispanic, Asian,
and white patients, far more diverse than studies using
representative samples of the U.S. population.
While the race/ethnic population was diverse, the socioe-
conomic status of the population was not. Most of the
patients were of very low income which limits the gener-
alizability of the study results. Missing data was also a lim-
itation. Missing quarterly A1C values was common but
mixed effects models still yield unbiased estimates pro-
vided that the missing data was missing at random (MAR)
[14].
Finally, multiple factors affect glycemic control. The
mixed effects model incorporated demographic, disease
severity, health status, access/quality of care, and behavio-
ral factors but these are just some of the possible factors
that affect glycemic control. Psychological and biological
factors, self-care skills, knowledge of disease and educa-
tion level, diet, exercise, other comorbid diseases, etc.
were not explained by this model. Nichols et al.'s [11]
study found that only 9% of the variability in glycemic
control was explained by the factors in their model and
suggested that personal characteristics may not explain a
lot of differences in glycemic control among patients with
Type 2 diabetes.
This study identified patients with poorer glycemic con-
trol in Project Dulce. The findings should not be general-
ized to all patients with Type 2 diabetes but can be applied
to racial/ethnically diverse, low-income populations.
Those who were uninsured, had diabetes for a longer
period of time, used insulin or multiple oral agents, or
had high cholesterol had poorer glycemic control. The
younger population also lagged behind others. Secondar-
ily, this study showed that a high proportion of the
patients were meeting ADA's blood pressure and choles-
terol recommendations, suggesting that communityPage 8 of 9
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disease management programs in low-income popula-
tions can be effective and may contribute to improved
health outcomes.
This study provides a useful methodology to assess dis-
ease management systems that collect longitudinal data. It
does not provide answers to why patients are not opti-
mally controlled but does provide a starting point from
which to investigate and address the obstacles that pre-
vent patients with diabetes from reaching their metabolic
targets.
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